MEDTRONIC PUERTO RICO OPERATIONS CO. INTELLIS; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF
|
Back to Search Results |
|
Model Number 97715 |
Device Problem
Overheating of Device (1437)
|
Patient Problems
Burning Sensation (2146); Injury (2348); Numbness (2415); Skin Inflammation (2443)
|
Event Date 05/10/2020 |
Event Type
malfunction
|
Manufacturer Narrative
|
Concomitant medical products: product id: 97755, serial#: (b)(4), product type: recharger.Product id: 97745, serial#: (b)(4), product type: programmer, patient.Other relevant device(s) are: product id: 97755, serial/lot #: (b)(4) , udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a consumer and a manufacturer representative regarding a patient with an implantable neurostimulator ( ins).It was reported that the patient noticed a blister on their skin, near the ins site, where the charging cord would sit during recharge.They had recharged on (b)(6) 2020 and (b)(6) 2020 to 100% and they stated they felt what they thought was a blister at the ins site.The patient went to the emergency room and the doctor started them on bactrim in case of cellulitis.They denied any heating/warmth at the ins site during the charge cycle.It was further reported that they didn't have much sensation in the implant area, so they didn't feel it getting hot.They would be returning the controller with the recharger that caused the injury.The manufacturer representative called in regards to the heating sensation and the blister at the ins site.The caller indicated that the patient had seen a healthcare provider about the issue and was prescribed antibiotics in case of cellulitis.No further complications were reported or anticipated.
|
|
Event Description
|
Additional information was received from a manufacturer representative (rep).It was reported that it was unknown if the replacement recharger resolved the issue and the rep attempted to contact patient and left message.No further complications were reported.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
H7: 97755 was returned, analysis found no anomaly.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Search Alerts/Recalls
|
|
|